Connect with us:

Facebook Twitter RSS

News & Updates

26 Oct 2012

Scientists discover potential new 'roots' of breast cancer

Scientists have discovered new types of immature cells in mammary glands, uncovering clues to the origins of different breast cancers - and potential new drug targets, according to findings published in Breast Cancer Research.

The team at Cancer Research UK’s Cambridge Research Institute identified at least two types of immature cells, called progenitor cells. Unlike stem cells, which can develop into any type of cell and keep on dividing, progenitor cells can only divide a limited number of times. Previously scientists only knew of one type of progenitor cells in mammary glands.

Cancer is thought to begin in cells that can produce many daughter cells, which form the tumour mass. So different progenitor cells may explain why there are different types of breast cancer.

The team discovered that one group of progenitor cells, called oestrogen positive progenitors, had oestrogen receptors. This protein receives signals from the sex hormone, oestrogen. The other group - oestrogen negative cells - lacked this receptor.

Oestrogen positive progenitor cells survive better in a low oestrogen and progesterone environment - similar to the breast tissue of post-menopausal women. This suggests that tumours in post-menopausal women may develop from these cells, but further experiments are needed to confirm this.

The oestrogen negative progenitor cells have a genetic fingerprint resembling an aggressive type of breast cancer called basal-like breast cancer, more likely to affect younger women. This suggests the disease may develop from the oestrogen negative progenitors.

Study author, Dr John Stingl, at Cancer Research UK’s Cambridge Research Institute, said: “This exciting discovery reveals that mammary glands are much more complicated than scientists initially thought. Uncovering new types of ‘mother’ cells may explain why there are different types of breast cancer, and why young and older women tend to get different types. It could also provide new starting points for ways to diagnose and treat the disease in the future.”

Dr Julie Sharp, Cancer Research UK’s senior science information manager, said: “This research takes us right to the root of how breast cells develop. This fresh understanding could reveal new ways to block the development of cancer and tell us more about what happens when tumours become resistant to treatment.

“Cancer Research UK is a major funder of breast cancer research in the UK. Our research has contributed to progress that means eight out of 10 women now survive breast cancer for more than five years, compared with five out of 10 women in the 1970s. But there’s much more to do. Research like this will build on our understanding of breast cancer to bring forward the day when we can beat this disease.”

The Cancer Research UK Cambridge Research Institute is a partner in the EurocanPlatform project.

Source: Cancer Research UK

More publications

14 Dec 2016: Preserving fertility in girls and young women with cancer “haphazard” say experts 23 Dec 2015: 'Hematological Malignancies: from Mechanisms to Therapy' symposium - March 9/12, 2016 - Milan 02 Dec 2015: European cancer centres finally united in long-term collaborative partnerships 19 Nov 2015: SiRIC-Curie Call for translational research group leaders, Paris, France 20 Oct 2015: IARC Fellowships for Cancer Research 03 Aug 2015: Optimizing sharing of hospital biobank samples: new EurocanPlatform paper published in Science Translational Medicine 17 Jul 2015: 3rd EurocanPlatform Summer School in Translational Cancer Research: Portugal, 12 – 16 October 2015 17 Jul 2015: NCT Heidelberg School of Oncology Fellowship Program in Translational Cancer Research - Call for applications 01 Jul 2015: EurocanPlatform project engages directly with patient groups at ECPC AGM 19 Jun 2015: EurocanPlatform Translational Research Course 12th - 16th October - Save the Date! 13 May 2015: Catch up on all the latest from the EurocanPlatform project in the May 2015 Newsletter 14 Apr 2015: New EurocanPlatform paper published in PLOS One 31 Mar 2015: Launch of personalised medicine survey: Literacy among healthcare professionals 30 Mar 2015: OECI Cancer Days 2015 in Porto, Portugal 10 Mar 2015: Workshop on circulating biomarkers in cancer 19 Feb 2015: Meeting report from the second EurocanPlatform summer school on translational cancer research published in ecancermedicalscience 27 Jan 2015: The January 2015 Newsletter is here! 21 Jan 2015: Most types of cancer not due to “bad luck”, says IARC 06 Jan 2015: Brand new videos available from the 2nd Translational Research Course 08 Dec 2014: New conference report for the EurocanPlatform Chemoprevention Meeting published in ecancermedicalscience 20 Nov 2014: The November 2014 Newsletter is here! 13 Nov 2014: IARC/WHO Fellowships 05 Nov 2014: Research course on circulating tumor cells (CTC) at the Karolinska Institute 28 Oct 2014: Eighth Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice 03 Oct 2014: Core values for a new cancer culture: six centres create Cancer Core Europe 01 Sep 2014: EurocanPlatform paper published in the Journal of Oncology Practice 18 Aug 2014: 4th Annual meeting of EurocanPlatform project, October 25-26th 2014 04 Aug 2014: EurocanPlatform Translational Cancer Research Summer Course, Portugal, October 20-24, 2014 31 Jul 2014: The Summer 2014 Newsletter is here! 18 Jun 2014: Role for an experienced scientist available at the Curie Institute 20 May 2014: New science policy paper published in Molecular Oncology 19 Feb 2014: Workshop on "Tissue-based Biomarkers for Advancement of Personalized Cancer Treatment" 21 Jan 2014: The second Advanced Lecture Course on Translational Cancer Research 21 Jan 2014: OECI and ECPC - How Uniform Is Cancer Care? February 18th 2014 31 Oct 2013: FDA pulls ponatinib approval due to blood clots and narrowing of blood vessels 22 Oct 2013: Publications from within EurocanPlatform - Year 2 09 Oct 2013: IARC: Postdoctoral fellowships for training in cancer research 12 Sep 2013: VHIO-Fritz Bender Foundation joint International Symposium 13 Aug 2013: HPV vaccine could also prevent oropharyngeal cancer, says IARC 13 Aug 2013: New ECPC Board of Directors 11 Jun 2013: EAPM Members Update: Discussion on the Data Protection Legislation 21 May 2013: Growing call to abandon impact factors 29 Apr 2013: New partnership between IARC and CRI to spur cancer research in Thailand and across South-East Asia 11 Apr 2013: OECI 2013 Oncology Days - including EurocanPlatform Session 08 Mar 2013: Spreading the cancer prevention message in Sierra Leone 25 Feb 2013: EAPM: Access to health data is essential for the development of new treatments 20 Feb 2013: Access to health data is essential for the development of new treatments, says European Alliance of Personalised Medicine 23 Jan 2013: Course in cancer genomics at EBI 19 Sep 2012: Personalised medicine promises radical improvements to healthcare in Europe